Homidium

Homidium

SCHEMBL11023665

Br.Br.Br.CC[n+]1c(-c2ccccc2)c2cc(N)ccc2c2ccc(N)cc21.CC[n+]1c(-c2ccccc2)c2cc(N)ccc2c2ccc(N)cc21.CC[n+]1c(-c2ccccc2)c2cc(N)ccc2c2ccc(N)cc21.CC[n+]1c(-c2ccccc2)c2cc(N)ccc2c2ccc(N)cc21.CC[n+]1c(-c2ccccc2)c2cc(N)ccc2c2ccc(N)cc21.CC[n+]1c(-c2ccccc2)c2cc(N)ccc2c2ccc(N)cc21.CC[n+]1c(-c2ccccc2)c2cc(N)ccc2c2ccc(N)cc21.CC[n+]1c(-c2ccccc2)c2cc(N)ccc2c2ccc(N)cc21.CC[n+]1c(-c2ccccc2)c2cc(N)ccc2c2ccc(N)cc21.CC[n+]1c(-c2ccccc2)c2cc(N)ccc2c2ccc(N)cc21.CC[n+]1c(-c2ccccc2)c2cc(N)ccc2c2ccc(N)cc21.CC[n+]1c(-c2ccccc2)c2cc(N)ccc2c2ccc(N)cc21.CC[n+]1c(-c2ccccc2)c2cc(N)ccc2c2ccc(N)cc21

nearest known ligand 0.97

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Homidium. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE known ✓ P22303 7/20 0.65
MEN1 O00255 5/20 0.97
KMT2A Q03164 5/20 0.97
MAPT P10636 5/20 0.97
BLM P54132 4/20 0.97
KDM4E B2RXH2 4/20 0.97
HPGD P15428 4/20 0.97
HTT P42858 4/20 0.97
CYP3A4 P08684 3/20 0.97
THRB P10828 3/20 0.97
CASP1 P29466 3/20 0.97
RECQL P46063 3/20 0.97
CASP7 P55210 3/20 0.97
TERT O14746 3/20 0.97
ALDH1A1 P00352 3/20 0.97
MAPK1 P28482 3/20 0.97
HSD17B10 Q99714 3/20 0.97
MITF O75030 2/20 0.97
NSD2 O96028 2/20 0.97
LMNA P02545 2/20 0.97

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Homidium SCHEMBL4354124 1.00 MEN1 (0.97) MEN1KMT2AMAPTBLMKDM4E
Homidium SCHEMBL7865385 0.99 MEN1 (0.94) MEN1KMT2AMAPTBLMKDM4E
Homidium SCHEMBL8777149 0.99 MEN1 (0.97) MEN1KMT2AMAPTBLMKDM4E
Homidium SCHEMBL17460393 0.99 MEN1 (0.94) MEN1KMT2AMAPTBLMKDM4E
Homidium SCHEMBL29391335 0.99 MEN1 (1.00) MEN1KMT2AMAPTBLMKDM4E
Homidium SCHEMBL27609 0.99 MEN1 (1.00) MEN1KMT2AMAPTBLMKDM4E
Homidium SCHEMBL21647365 0.99 MEN1 (1.00) MEN1KMT2AMAPTBLMKDM4E
Homidium SCHEMBL31511751 0.99 MEN1 (1.00) MEN1KMT2AMAPTBLMKDM4E
Homidium SCHEMBL1879927 0.97 MEN1 (0.97) MEN1KMT2AMAPTBLMKDM4E
Homidium SCHEMBL19690770 0.97 MEN1 (0.97) MEN1KMT2AMAPTBLMKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0057553-B1 METHOD FOR THE FLUORESCENT DETECTION OF DAMAGED DNA AND KIT FOR USE THEREIN ATOMIC ENERGY OF CANADA LIMITED (CA) 1985-05-08 EP disclosed
US-4407942-A SCREENING EFFECTS OF DRUGS, RADIATION AND CHEMICALS ATOMIC ENERGY OF CANADA LIMITED (CA) 1983-10-04 US disclosed
EP-0057553-A1 Method for the fluorescent detection of damaged DNA and kit for use therein ATOMIC ENERGY OF CANADA LIMITED (CA) 1982-08-11 EP disclosed